Gender affirmative HIV care framework: Decisions on feminizing hormone therapy (FHT) and antiretroviral therapy (ART) among transgender women.
Arjee Javellana RestarE Karina SantamariaAlexander AdiaJennifer NazarenoRandolph ChanMark LurieTheodorus G M SandfortLaufred HernandezSusan Cu-UvinDon OperarioPublished in: PloS one (2019)
There exist mixed regimens and beliefs about taking FHT and ART among this sample of trans women. While trans participants' main source of health information is their HIV provider, providers are likely to communicate non-affirmative rhetoric that negatively impacts trans women's decision to take FHT and ART. Research is needed to elucidate co-prescriptions of gender-affirmative services with HIV care among this group in the Philippines.
Keyphrases
- antiretroviral therapy
- hiv infected
- polycystic ovary syndrome
- human immunodeficiency virus
- hiv positive
- health information
- hiv aids
- hiv infected patients
- mental health
- pregnancy outcomes
- primary care
- healthcare
- cervical cancer screening
- social media
- breast cancer risk
- hiv testing
- insulin resistance
- south africa
- metabolic syndrome
- skeletal muscle
- adipose tissue
- decision making
- replacement therapy